Pharmaceuticals

German Doctors Stand by MS Drugs Despite Warning

Recipharm and Isofol Medical in Exclusive Drug Development

Roche to buy US Biotech Firm InterMune for $8.3 Billion

Aesica Appoints New Product Release Manager

Mylan Trims Forecast Due to FDA Approval Delays

Carbogen Amcis to Take Over High-Containment Facility

Topics • Strategy

Multichannel Excellence: The Competitive Factor for Pharma

Topics • Strategy

German Chemical Producers See TTIP as a “Political Chance”

US-UK Deal Creates Expanded Drug Services Player

German Chemical Producers See TTIP as a “Political Chance”

Roche Alzheimer's Drug Fails Main Goals in Mid-stage Study

Novartis and Banner in Alzheimer’s Genetic Predisposal Study

AbbVie Hikes Bid for Shire to $51 Billion

Belgium's Omega Pharma May Sell Itself

Roche to Buy US Biotech Firm Seragon for up to $1.7 Billion

Eli Lilly Copy of $8 Billion Sanofi Insulin Wins EU Approval

Shire Rejects AbbVie's £27 Billion Takeover Bid

Former Novartis Employee Suspected of Data Manipulation

Alexion Recalls Certain Lots of Intravenous Drug Soliris

Novo Nordisk Launches Diabetes Drug in Germany After Rethink

GSK Invites Private Equity Bids for Older Drugs

US Court Dismisses Teva Case to Block Generic Copaxone

Topics • Strategy

Maximum Return on Surplus and idle assets

UK Prime Minister Calls on Pfizer for More Guarantees

Topics • Strategy

International Drugmakers Meet Challenges

UK May Use Public Interest Against Pfizer’s AstraZeneca Bid

Pfizer Ups Offer for AstraZeneca to $106 Billion

Merck Consumer Unit Said to be Worth $14 Billion for Bayer

Sanofi Said Eyeing Drug Divestments of Over $7 Billion

Pfizer Chases AstraZeneca for Potential $100 billion Deal

Actavis Sues FDA Over Generic of Pfizer’s Celebrex

Bayer and Reckitt Said Finalists for Merck & Co. Consumer Arm

Valeant, Ackman Make $47 billion offer for Allergan

Pfizer Said to be Interested in AstraZeneca

Novartis and Lilly Clinch Animal Health Deal

386 more articles

Top-Feature

Global Impact Coalition (GIC)

Siemens Joins the Global Impact Coalition

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

Agilent Technologies Inc.

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

BIO Deutschland e.V.

German Biotech Days 2026: Biotechnology as The Key to Industrial Competitiveness

Special Issue

Circular Plastics Economy

Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Simon-Kucher & Partners Strategy & Marketing Consultants GmbH

Chemical Market Reporter

Porsche Consulting

Dr. Partsch & Partner

Helsinn Chemicals SA

Chemgineering Technology GmbH

Clea Technologies B.V.

Sustainability Support Services (Europe) AB

Thomson Reuters

High Technology Associates

Berlin Partner für Wirtschaft und Technologie GmbH

American Chemistry Council

Cedarburg Hauser Pharmaceuticals

Camelot Management Consultants AG

Saltigo GmbH

WeylChem International GmbH

Bio Evaluation

Arthur D. Little

Society of Chemical Manufacturers & Affiliates (SOCMA)

A.T. Kearney GmbH

Robert Bosch GmbH

Cambrex Corporation

Chemtura Corp.

Informa Markets

Oracle Germany

CPA Chemical Pharmac. Ass.

Cerbios-Pharma SA

Dechema e.V.

EquipNet Inc.